Stereotaxis, Inc. (NYSEAMERICAN:STXS – Get Free Report) Director Paul J. Isaac acquired 23,299 shares of Stereotaxis stock in a transaction dated Thursday, March 6th. The shares were bought at an average cost of $1.81 per share, for a total transaction of $42,171.19. Following the completion of the purchase, the director now directly owns 49,066 shares of the company’s stock, valued at approximately $88,809.46. The trade was a 90.42 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Stereotaxis Stock Up 1.1 %
Shares of NYSEAMERICAN:STXS opened at $1.79 on Wednesday. The company’s 50-day moving average is $2.25. The company has a market capitalization of $151.67 million, a PE ratio of -6.39 and a beta of 1.54. Stereotaxis, Inc. has a 12-month low of $1.66 and a 12-month high of $3.29.
Institutional Trading of Stereotaxis
Institutional investors have recently modified their holdings of the company. ProShare Advisors LLC boosted its holdings in shares of Stereotaxis by 53.6% during the fourth quarter. ProShare Advisors LLC now owns 15,913 shares of the company’s stock worth $36,000 after purchasing an additional 5,556 shares during the period. Two Sigma Securities LLC purchased a new stake in shares of Stereotaxis during the fourth quarter worth about $54,000. SG Americas Securities LLC boosted its holdings in shares of Stereotaxis by 39.2% during the fourth quarter. SG Americas Securities LLC now owns 26,360 shares of the company’s stock worth $60,000 after purchasing an additional 7,417 shares during the period. Wells Fargo & Company MN boosted its holdings in shares of Stereotaxis by 53.7% during the fourth quarter. Wells Fargo & Company MN now owns 26,915 shares of the company’s stock worth $61,000 after purchasing an additional 9,403 shares during the period. Finally, Jane Street Group LLC lifted its holdings in Stereotaxis by 26.9% in the third quarter. Jane Street Group LLC now owns 29,773 shares of the company’s stock worth $61,000 after buying an additional 6,313 shares during the period. 45.35% of the stock is currently owned by hedge funds and other institutional investors.
Stereotaxis Company Profile
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
See Also
- Five stocks we like better than Stereotaxis
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.